Published November 19, 2026 · By
UnitedHealth stock fell again on Thursday, extending a three-session slide that began after federal regulators proposed tougher audits of Medicare Advantage plans. Shares of the nation's largest health insurer traded about 5% lower in the afternoon, near $333, after a drop of roughly 10% on Wednesday. Other insurers that rely on Medicare Advantage, including Humana, Elevance Health and CVS Health, also lost ground this week.
The sell-off follows a Centers for Medicare & Medicaid Services (CMS) proposal that the agency says would save taxpayers nearly $90 billion over 10 years by targeting fraud and improper payments. Here is what happened, what each side has said and what it could mean for you.

UnitedHealth Stock Slide: What Happened This Week
On Monday, Nov. 16, the Department of Health and Human Services announced a proposed rule called Comprehensive Regulations to Uncover Suspicious Healthcare, or CRUSH. It covers Medicare, Medicaid, the Children's Health Insurance Program and the Affordable Care Act Marketplace.
Investors focused on the Medicare Advantage portion, and UnitedHealth stock took the biggest hit among large names. On Wednesday, Nov. 18, UnitedHealth stock closed down about 10.2% at $349.91, according to market data compiled by financial news sites. Humana fell nearly 13%, Elevance Health dropped about 7.6%, CVS Health slid about 5% and Cigna lost about 3%. Health care was the weakest sector of the day.
Because UnitedHealth stock carries a heavy weight in the price-weighted Dow Jones Industrial Average, its drop helped pull the Dow down 561 points to 50,198.17 on Wednesday.
Thursday's Moves
The pressure continued on Thursday. Investing.com reported that UnitedHealth stock opened at $351.59, hit an intraday low of $324.67 and was down 4.8% at $333.23 in the afternoon. Yahoo Finance noted the shares were on track for a slide of about 18% over five days.
The broader market also fell. Reuters reported the Dow was down about 1,000 points, or 2%, in early afternoon trading, as investors weighed the stock market debut of AI company Anthropic, higher oil prices and a rotation out of health care stocks. Final closing figures were not available at the time of writing, so UnitedHealth stock could still end the day higher or lower than these levels.
What the CRUSH Rule Would Change
According to the HHS announcement, the proposal would give CMS new tools across several programs. For Medicare Advantage, the private-plan alternative to Original Medicare, the key changes include:
- Stronger Risk Adjustment Data Validation (RADV) audits to find and recover payments when a patient's diagnosis is not supported by medical records.
- A requirement that Medicare Advantage organizations and Part D sponsors report all suspicious or substantiated fraud, waste and abuse to CMS.
- A requirement that providers who bill Medicare Advantage plans also enroll in Original Medicare.
This matters for UnitedHealth stock because the company is the largest Medicare Advantage insurer in the country. Medicare Advantage plans receive higher payments for members with more serious documented health conditions. RADV audits check whether those diagnoses are backed up by medical records. If they are not, CMS can seek to recover the money.
Medicaid and the Marketplace
The rule also reaches beyond Medicare. States could act on "credible allegation of fraud" findings made by CMS or another federal agency, and eligible Medicaid providers would need a National Provider Identifier. In the ACA Marketplace, agents and brokers with certain felony convictions could be restricted, and CMS could suspend them right away over credible allegations of abusive conduct. The plan also adds safeguards against access to enrollment systems from outside the U.S.
The full details are in the official HHS announcement. Public comments are due Jan. 19, 2027.
What Officials, Lawmakers and Analysts Said
HHS Secretary Robert F. Kennedy Jr. said the rule would give CMS stronger tools to block fraudulent payments and remove dishonest providers. CMS Administrator Dr. Mehmet Oz said it would build on earlier anti-fraud results. CMS Deputy Administrator Kim Brandt said that "for too long, the system has paid first and asked questions later."
On Capitol Hill, Democratic Sen. Elizabeth Warren renewed her calls to break up vertically integrated health care companies and named UnitedHealth, Investing.com reported. The same report said Sen. Bernie Sanders, an independent who caucuses with Democrats, outlined plans to push for expanded Medicare eligibility. Bloomberg linked Thursday's insurer losses to both the audit proposal and the Sanders plan.
On Wall Street, Mizuho analyst Ann Hynes described the expanded audit scrutiny as a negative for Medicare Advantage profit margins and named UnitedHealth and Humana as the most exposed, according to Investing.com. Oppenheimer analysts said they expect the proposal to face legal challenges.
The reports reviewed for this article did not include public responses from UnitedHealth or Humana on the proposal.
How Big Is the Drop?
UnitedHealth stock closed near $390 on Tuesday, based on Wednesday's reported close and percentage loss. A move to the low $330s means the company has lost roughly 15% of its market value in two sessions. Humana, which depends even more heavily on Medicare Advantage, posted the sharpest single-day decline among major insurers on Wednesday. Our analysis: the size of the drop shows how sensitive these companies are to changes in federal payment rules, since Medicare Advantage is one of their biggest sources of revenue.
Why the Market Reacted So Strongly
Our analysis: the moves in UnitedHealth stock suggest investors are weighing two risks at once. The first is that tougher audits could force insurers to repay money and lower future payments. The second is political, with Democrats set to gain influence in Congress next year and some calling for structural changes. Neither risk is settled, since the rule is only a proposal and any legislation would need to pass Congress.
UnitedHealth Stock and What It Means for You
The headlines are mostly about investors, but the proposal touches millions of households. Here is how it may affect you, depending on your situation.
If You Have a Medicare Advantage Plan
Nothing changes today. CRUSH is a proposed rule, so it does not alter your current benefits or the plan you picked for 2027. Medicare open enrollment runs through Dec. 7, and the usual advice still applies: compare premiums, drug coverage and provider networks before the deadline. Our guide to Medicare 2027 open enrollment costs explains what to check.
Over time, insurers facing lower payments could respond by adjusting benefits, networks or the counties they serve. That is a possibility analysts watch, not a confirmed outcome.
If You Own Stocks or Index Funds
Many Americans own UnitedHealth stock indirectly through 401(k) plans, IRAs or index funds that track the Dow or the S&P 500. A large drop in one heavyweight company can move those funds, but diversified portfolios spread the risk across many holdings. Short-term swings like this week's are common around major policy news, and UnitedHealth stock may stay volatile while the rule is debated.
This article is for information only and is not financial advice; speak with a licensed professional before making investment decisions.
If You Use Medicaid or the ACA Marketplace
Most of the Medicaid and Marketplace changes target providers, agents and brokers, not enrollees. You may still see more verification steps. For background on how states are handling Medicaid, see our report on Medicaid expansion hurdles in four states.
What to Watch Next for UnitedHealth Stock
- Jan. 19, 2027: deadline for public comments on the CRUSH proposal.
- A final rule: CMS must review comments before it can finalize any changes, and the final version could differ.
- Possible lawsuits: Oppenheimer analysts expect legal challenges.
- Company guidance: any updated outlook from UnitedHealth, Humana or other insurers.
- Congress: whether Medicare expansion or breakup proposals gain traction next year.
For now, UnitedHealth stock remains tied to how Washington's audit plans develop, and the coming weeks may bring more detail from both regulators and the companies.
Sources: U.S. Department of Health and Human Services (hhs.gov); American Hospital Association News; Reuters; Yahoo Finance; Investing.com; Bloomberg.